Publication | Closed Access

Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination

VaccinationVaccine SafetyPreventive MedicineVaccine SurveillanceMf59-adjuvanted H1n1v VaccinationItalian Post-marketing SurveillanceVaccine EfficacyInfection ControlPublic HealthVaccine HesitancyMedicineAdverse Event ReportsEpidemiology